Markers of Executive Attention Development in Preschoolers

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04548245

Acronym

MEDiATE

Enrollment

Registered

2020-09-14

Start date

2021-02-01

Completion date

2023-10-01

Last updated

2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder

Brief summary

This project aims to identify precursors of executive attention that can serve as early markers of ADD.

Interventions

DEVICEEEG

EEG

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

48 Months to 60 Months

Healthy volunteers

Yes

Inclusion criteria

* Normal schooling * Parental consent

Exclusion criteria

\- Psychotropic drug

Design outcomes

Primary

Measure	Time frame
Amplitude in µV of EEG changes relative to baseline when expected stimulus is omitted in a tactile stimulation sequence	at 4 years old

Countries

France

Contacts

Primary ContactNadege Roche-Labarbe, PhD

nadege.roche@unicaen.fr+33(0)649922568

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026